CAMBREX CORP
10-Q, EX-27, 2000-08-15
INDUSTRIAL ORGANIC CHEMICALS
Previous: CAMBREX CORP, 10-Q, 2000-08-15
Next: DEUCALION RESEARCH INC, NT 10-Q, 2000-08-15



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          53,113
<SECURITIES>                                         0
<RECEIVABLES>                                   78,932
<ALLOWANCES>                                     1,182
<INVENTORY>                                    101,067
<CURRENT-ASSETS>                               260,837
<PP&E>                                         292,979
<DEPRECIATION>                                 206,585
<TOTAL-ASSETS>                                 707,654
<CURRENT-LIABILITIES>                           78,548
<BONDS>                                        223,996
                                0
                                          0
<COMMON>                                         2,698
<OTHER-SE>                                     314,509
<TOTAL-LIABILITY-AND-EQUITY>                   707,654
<SALES>                                        251,788
<TOTAL-REVENUES>                               252,654
<CGS>                                          157,759
<TOTAL-COSTS>                                   49,087
<OTHER-EXPENSES>                                    90
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,022
<INCOME-PRETAX>                                 39,876
<INCOME-TAX>                                    13,358
<INCOME-CONTINUING>                             26,518
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    26,518
<EPS-BASIC>                                       1.07
<EPS-DILUTED>                                     1.02


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission